SlideShare une entreprise Scribd logo
1  sur  6
Télécharger pour lire hors ligne
Prices Increase After
                                                                                    August 13th
PROUDLY PRESENTS




     original
                The
                              InvestIgator
                           12th
     is still the best!
     Join us and share
     Best Practices with
                           InItIated trIals
       organizations           New IIT Content includes Aggregate Spend, M&A,
         including:            Emerging Markets, Publication Planning and more!
               abbott          September 27-28, 2010
              allergan         Hyatt regency San FranciSco airport - burlingame, ca



                                                         {
         astraZeneca
                                                              7th MSL Best Practices
              celgene           Co-LoCated                    Register Today and Gain Access to Presentations
                                                              from Both Events!
              centocor
                                Safety Reporting
                                                                                     Sunshine Act
               iiSra
   Johnson & Johnson            Us Vs. Ex-Us    Training
               merck
                                 FMV       Aggregate Spend Contracting
         millennium
                                                                           Emerging Markets
                              Pub Planning
                                                             Compliance Transparency
               pfizer
  Vertex pharmaceuticals            Mergers & Acquisitions

                             IP       Grants Systems                                Process
SPONSORS &                                                   ASSOcIATION
EXHIBITORS:                                                  PARTNERS:




  To Register Call 866-207-6528 or Visit Us at www.exlpharma.com/events/12th-investigator-initiated-trials
WHO WILL BE IN                                                                SponSorSHip
ATTENDANCE?                                                                   and exHibiting
•	   Investigator	Initiated/Sponsored	Trials                                  opportunitieS
•	   Investigator	Research                                                    do you want to spread the word about your or-
•	   Medical	Affairs/Field	Medical	Affairs                                    ganization’s solutions and services to potential
•	   MSL	Managers/Field	MSLs                                                  clients who will be attending this event? take ad-
•	   Clinical	Research	Associates                                             vantage of the opportunity to exhibit, present an
•	   Phase	IV                                                                 educational session, host a networking event, or
                                                                              distribute promotional items to attendees. exl
•	   Legal	&	Regulatory	Affairs                                               will work closely with you to customize a package
•	   Clinical	and	Research	Investigators                                      that will suit all of your needs. to learn more about
•	   Site	Management	                                                         these opportunities, contact lucas carrasco, busi-
•	   Post-Market	Studies                                                      ness development, by calling 212-400-6231 or by
•	   Clinical	Affairs                                                         emailing lcarrasco@exlpharma.com.
•	   Clinical	Data	Analysts


rave reviews from exl’s 11th investigator-initiated trials:
“this was an excellent meeting. it covered a broad range            “great presenter and covered exactly what i was looking
of important issues. Speakers are very knowledgeable and            for!” Rina Patel, Medical affairs Manager, aLLerGan
very approachable,”                                                 “clear, concise info w/good value-added
Randy Leeder, Clinical Project Manager, Leo PharMa
                                                                    recommendations,”
“excellent, as usual,” Lindsay Tollen, Senior Manager, CePhaLon     Therica Miller, Manager Clinical trials office, nevada Cancer institute
“great topics - important issues,”                                  “yes! great presentations and workshops! good
Muriel Siadak, associate Medical Director, SeattLe GenetiCS         discussions,” Teresa Pena, aD Scientific exchange, uCB
“great! exceeded expectations. new data/material; well              “thoughtful, interactive constantly touching back to
done presentations, excellent value drive conference!”              mission, goals, value argument,”
Patrician Westergren, Product Mgr, iiSr, MeDnet SoLutionS           Laura Williams, Principal Grant and Contract administrator, uMn
“yes – no improvements needed,”
Coleen Myers, Clinical research Manager, CePhaLon



HOTEL INFORMATION

                                               Hyatt Regency              reward yourself with a stay at the Four diamond Hyatt regency San
                                               San FRanciSco              Francisco airport hotel. experience our ideal location on San Francisco
                                               airport                    bay – just 15 minutes from the excitement of downtown San Francisco
                                               1333	Bayshore	Highway,	    or the technology corridor of Silicon Valley and only seven minutes from
                                                                          San Francisco international airport, you’ll enjoy easy access to all the
                                               Burlingame,	California,	
                                                                          sanfrancisco airport attractions surrounding our luxury hotel.
                                               USA	94010	
                                               Tel:	+1	650	347	1234	  	
                                               Fax:	+1	650	696	2669       reSerVationS:
                                                                          please make reservations before September 5th


        to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
day one, monday, September 27, 2010
8:00 registration and Continental Breakfast for WorkshoP PartiCiPants




                                                                                                                                                              WorkshoP
                                                                                                                                                                    Pre-ConferenCe
PRE-cONfERENcE WORkSHOP
9:00     examining the compliance, execution and data management challenges of tracking aggregate Spend
         Legal Overview of Sunshine Act
•	   Compliance	Focus                                                          •	   Managing	Master	Spend	Data	
	    ·	 Implementing	efficient	tracking	systems	                               	    ·	 Identifying	data	sources	and	data	flow	associated	with		IITs
	    ·	 Key	compliance	challenges                                              	    ·	 Management	processes	for	data
	    ·	 Identifying	and	mitigating	risks	                                      	    ·	 Analyzing	and	reporting	systems
	    ·	 Addressing	HCP	interactions	concerning		payments                       	    ·	 Implementing	process	improvements
Wendy Tsuei, Sr. Program Manager, Corporate Compliance, AllergAn               	    ·	 Ensuring	data	integrity
                                                                               Ahmad Chaudhri, Director, Business Analytics, AllergAn

Allocated Time for Questions, Answers and Scenarios for maximum participant involvement

10:30 netWorking and refreshment Break

12:00 lunCh for WorkshoP attendees



                                        main ConferenCe oPens
12:00 registration oPens for main ConferenCe                                            3:45    understanding the role of publication planning
                                                                                                Valérie Philippon, PhD, Director, Publications, VerTeX PHArMACeUTICAlS
1:00    chairperson’s welcome                                                           	       •		Publication	Planning	Overview
Karen Bartels, RN, OCN, MBA, PMP, Clinical Project Manager,                             	       •		Incorporating	the	Publication	Clause	in	the	IIT	Agreement
ASTrAZeneCA & eXeCUTIVe DIreCTOr, IISrA                                                 	       •		Maximizing	the	Value	of	Publications
                                                                                        	       •		Differences	between	IIT	and	Clinical	Publication	Review

            HOW M&A AffEcTS IIT PROgRAMS ANd TRIAlS
                                                                                                              IISRA uPdATE & ROuNdTABlES
1:15    adopting and implementing processes while
        maintaining the integrity of trials obtained through                            4:30	   investigator initiated Sponsored research
        mergers and acquisitions                                                                association update
                                                                                                Karen Bartels, RN, OCN, MBA, PMP, Clinical Project Manager,
        Alex Kostek, Global Investigator Initiated Research Group Leader, PFIZer                ASTrAZeneCA & eXeCUTIVe DIreCTOr, IISrA
        Deborah Cassel, Associate Director, Global Center for Scientific Affairs,       	       IISRA	values	your	input.	Your	feedback	has	significantly		
        Merck Investigator Studies Program (MISP), MerCK                                	       contributed	to	the	development	of	Standards	and	Best		
	       •	 Process	overview	of	compliantly	and	efficiently	taking	on	new		              	       Practice	Guideline	and	position	statements.	
	       	 IITs	as	a	result	of	mergers	and	acquisitions
	       •	 Determining	which	IITs	should	be	adopted	and	which	can		 	                   	       •	Membership	and	organizational	milestones
	       	 contractually	be	let	go                                                       	       •	Standards	and	Best	Practice	Committee	Deliverables
	       •	 Guidance	on	planning	and	executing	integration	plans	in		                    	       •	Membership	committee	and	related	subcommittees
	       	 different	scenarios

             ONlINE IIT APPROvAl SuBMISSION PROcESS                                     ROuNdTABlES dIScuSSION
2:15    case report - on-line automation of iit grants                                  5:00	   cocktail reception
        management: System design to global implementation                                      roundtable discussion. Sessions on topics including:
	       Anton ehrhardt, PhD, Sr. Medical Director,                                      	       •	Aggregate	Spend
        MIllenIUM: THe TAKeDA OnCOlOgY COMPAnY                                          	       •		IISRA	Breakout
	       •	 Advantages	and	challenges	of	building	a	completely	custom		                  	       •	Global	IITs
	       	 system                                                                        	       •	Publication	Planning
	       •	 Integration	with	existing	infrastructure	to	support	Aggregate		              	       •	Safety	Reporting
	       	 Spend	Reporting	&	Transparency	Initiatives                                    	       •	Grant	Management	Systems
	       •	 Why	you	should	consider	doing	this	too
                                                                                        Attendees will have additional topic roundtables to choose from
                                                                                        focusing on MSL-related topics
3:15 netWorking and refreshment Break

                                                                                        6:00 Close of day one




                to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
day two, tueSday, September 28, 2010
                 main ConferenCe
8:00 Continental Breakfast for ConferenCe                                                        of	program	has	its	benefits,	but	also	its	challenges.	 I	will	discuss	
     PartiCiPants                                                                                these	and	highlight	some	key	points	that,	based	on	my	experience,	
                                                                                                 should	 be	 taken	 into	 account	 when	 setting	 up	 a	 competitive	
8:50    chairperson’s day one recap                                                              program.	 These	include:
        Karen Bartels, RN, OCN, MBA, PMP, Clinical Project Manager,                      	       •	 Healthcare	Professional	payments
        ASTrAZeneCA & eXeCUTIVe DIreCTOr, IISrA                                          	       •	 Program	set	up
                                                                                         	       •	 Internal	review	committee’s	role
                                                                                         	       •	 Review	process	and	meeting
                      kEy PERfORMANcE INdIcATORS                                         	       •	 Post	meeting	activities

9:00	   How to terminate an iit and maintain relationships
                                                                                                                     PuBlIcATION Of IITS
        with investigators
        Ashwaq Hermes, PharmD Sr. Clinical Science ManagerGlobal                         11:45   How the Sunshine act has impacted iit programs and
        Pharmaceutical Research & Development, ABBOTT
        After	several	months	of	hard	work	generating	adequate	interest,	                         investigator interactions
        completing	the	proposal,	the	protocol,	consent	form,	IRB	approval,	                      Dennis Decktor, PhD, MBA, Senior Director, Medical Affairs,
        CRFs	and	contracts,	the	project	officially	starts!	Months	later,	it	is	                  CenTOCOr OrTHO-BIOTeCH
        not	progressing!	What	are	the	options?
	       •	 What	are	the	causes	of	the	lack	of	progress?	Are	they	fixable?
	       •		What	if	they	are	not?	How	do	you	terminate	the	project?                       12:30 lunCh
	       •		How	do	you	terminate	the	project	while	preserving	your		
	       	 relationship	with	the	investigator(s)?                                                                      INTERNATIONAl IITS

                                                                                         1:30    iit contracting Strategies
                  kEyS TO SuccESSful IIT PROgRAMS                                                Annette S. Meints, RN, MS, PMP, Clinical Research Manager II,
9:45    walking the compliance tightrope – do you Have a                                         GPRD, ABBOTT
                                                                                                 This	session	will	provide	an	overview,	strategies	and	relevant	case	
        Funambulist on your Staff?                                                               examples	to	draw	from.	 The	following	items	will	be	included	in	
        Joseph Bray, Product Lead, UBC: envision                                                 the	discussion:	 
        Compliance	 today	 is	 a	 hot	 button	 discussion	 on	 everyone’s		                      ·	 Contract	structure,	format	and	key	components
        agenda.	 What	 is	 an	 acceptable	 risk	 for	 one	 company	 is	 toxic	 to		              	·	 Intellectual	Property	–	Whose	data	is	it?	
        another.	What	are	the	rules?	Who	gets	to	interpret	them?	Is	your		                       ·	 Publication	rights	
        SOP	 compliant	 in	 today’s	 world?	 How	 do	 we	 bring	 global		                        ·	 Confidentiality	concerns	
        IIT	 programs	 together	 under	 one	 set	 of	 working	 practices?		                      ·	 Indemnification	
        What	 constitutes	 influence?	 Small	 or	 large:	 biotech,	 Pharma,		                    ·	 Maximizing	compliance	and	mitigating	delays	
        or	 device	 company,	 we	 all	 have	 a	 lot	 of	 the	 same	 questions.	   In		
        this	 session	 we	 will	 attempt	 to	 look	 at	 both	 sides	 of	 the	 many		
        decisions	 each	 company	 must	 make	 when	 developing	 a		
                                                                                                                      INTERNATIONAl IITS
        compliant	IIT	program.	
	       •	 Initial	submission	–	Who’s	idea	is	it?
	       •	 Review	committee	invitations	–	Does	my	opinion	count?                         2:15    effective Strategies for managing investigator initiated
	       •	 Multisite	or	coop	studies	–	My	contract	is	with	who?                                  trials in emerging markets
	       •	 Payments	–	How	do	you	measure	study	progress?                                         Kevin Douglass, Associate Director/Investigator Initiated Research (IIR)
	       •	 Are	we	there	yet?	–	What	is	your	definition	of	done?                                  Manager, Emerging Markets, PFIZer
	       •	 Who	cares	how	they	do	it	over	there?	–	You	do,	it’s	a	global	                 	       •	 How	does	the	process	differ	from	US	IITs?
	       	 program                                                                        	       •	 Managing	multiple	emerging	market	sites
                                                                                         	       •	 Dealing	with	differences	in	culture	while	not	compromising		
                                                                                         	       	 the	integrity	of	the	IIT
10:30 netWorking and refreshment Break

                      cOMPETITIvE gRANT PROgRAM
                                                                                         3:00 ChairPerson’s Closing remarks;
                                                                                              ConferenCe adjourns
11:00   implementing competitive grants programs in place
        of iir Submissions
        Alison Curtin, Associate Director, Global IIR Primary Care, PFIZer
        A	 product	 team	 or	 disease	 area	 may	 choose	 to	 implement	 a	
        competitive	grant	program	in	addition	to	or	in	place	of	accepting	
        individual	 IIR	 submissions.	 This	 type	 of	 program	 typically	 has	
        a	 defined	 set	 of	 research	 criteria,	   which	 is	 broadly	 publicized	
        to	 an	 appropriate	 investigator	 group	 through	 one	 of	 several	
        possible	 routes	 (ie	 professional	 journal	 or	 website).  	 Submitted	
        applications	 are	 then	 are	 reviewed	 and	 approved	 by	 an	 external		
        advisory	committee,	in	lieu	of	a	formal	internal	review. 	This	type	


        to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
media Partners




                                                                              Group Discount proGram
                           Five Ways to reGister:
                                                                              Save 25% per person when Registering Four*
                           Fax:     888-221-6750                              For	every	three	simultaneous	registrations	from	your	company,	you	
                           Mail:    exl events, Inc.                          will	receive	a	fourth	complimentary	registration	to	the	program	(must	
                                                                              register	4	at	one	time)	this	is	a	savings	of	25%	per	person.		
                                    555 8th Ave, Ste 310
                                    new York, nY 10018
registration information




                                                                              Save 15% per person when Registering Three*
                           Phone: 866-207-6528                                Can	only	send	three?		You	can	still	save	15%	off	of	every	registration.		
                           Online: www.exlpharma.com
                           email: registration@exlpharma.com                  To	find	out	more	on	how	you	can	take	advantage	of	these	group	
                                                                              discounts,	please	call	212-400-6240	866-207-6528.			

                                                                              *All	discounts	are	taken	off	of	the	standard	pricing,	discount	offers	
                                                                              may	not	be	combined
                           reGistration Fees For attenDinG
                           exL’s 12th InvestIgator InItIated                  Make	checks	payable	to	ExL Events, Inc. and write code P1605
                           trIals:                                            on your check. 	You	may	also	use	Visa,	MasterCard,	Discover	or	
                                                                              American	Express.		Payments	must	be	received	in	full	prior	to	the	
                                                                              commencement	of	the	conference.
                           eaRLy BiRD PRicing                                 Cancellations:	If	you	need	to	cancel	your	registration	for	an	upcom-
                           Register by Friday August 13th to Take Advantage   ing	ExL	conference,	please	note	the	following	policies	derived	from	
                           of Early Bird Pricing:                             the	Start	Date	of	the	event:
                                                                              • Four weeks or more:	A	full	refund	(minus	a	$95	processing	fee),	or	
                           Conference + Workshop                   $1995      a	voucher	to	another	ExL	event	valid	for	two	years	from	the	voucher	
                           Conference Only                         $1695      issue	date.
                                                                              • Four weeks or Less:	A	voucher	to	another	ExL	event	valid	for	two	
                                                                              years	from	the	voucher	issue	date.
                           StanDaRD PRicing
                                                                              •	To	receive	a	refund	or	voucher,	please	fax	your	request	to	888-221-
                           Register After August 13th:                        6750.
                           Conference + Workshop                 $2195        • There will be an administrative charge of $300 to substitute,
                           Conference Only                       $1895        exchange and/or replace attendance badges with a colleague oc-
                                                                              curring within five business days of the conference.
                                                                              Please Note:	Speakers	and	agenda	are	subject	to	change	without	
                                                                              notice.	In	the	event	of	a	speaker	cancellation,	every	effort	to	find	a	
                           onSite PRicing                                     suitable	replacement	will	be	made.
                           Conference + Workshop                 $2295        *The	opinions	of	this	faculty	do	not	necessarily	reflect	those	of	the	
                           Conference Only                       $1995        companies	they	represent	or	ExL	Events,	Inc.*


                                                                              Questions? comments?
                                                                              Do	you	have	a	question	or	comments	that	you	would	like	to	be	
                                                                              addressed	at	this	event?		Would	you	like	to	get	involved	as	a	
                                                                              speaker	or	discussion	leader?		
                                                                              Please email Conference Director, Ethan Denkensohn at
                                                                              edenkensohn@exlpharma.com
Prices Increase After
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        August 13th
                                                                                                                                                                                                                                                                                                                                                                                                                                                                      PROUDLY PRESENTS
                                                                                Exp. Date:




                                                                                                                                                                                                                                                                                                                                                                         PLEASE MENTION PRIORITY CODE: P121




                                                                                                                                                                                                                                                                                                                                                                                                                                                                          original
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  12th InvestIgator
                                                                                                                                                                                                                                                                                                                                             555 8th Avenue, Suite 310




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  InItIated trIals
                                                                                                                                                                                                                                                                                                                                                                                                                                                                          is still the best!
                                                                                                                                                                                                                                                                                                                                             New York, NY 10018




                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Join us and share
                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Best Practices with
                                                                                                                                                                                                                                                                                                                                                                                                                                                                            organizations
                                                                                                                                                                                                                                                                                                                                                                                                                                                                              including:              New IIT Content includes Aggregate Spend, M&A,
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Emerging Markets, Publication Planning and more!
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     abbott
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      September 27-28, 2010
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     allergan         Hyatt regency San FranciSco airport - burlingame, ca
                                                                                                      Name on Card
                                                                                Card Number




                                                                                                                                                                                                                                                                                                                                                                                                                                                                               astraZeneca
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  {
                                                                                                                                                Signature




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     celgene                                           7th MSL Best Practices
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Co-LoCated                    Register Today and Gain Access to
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 centocor
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Presentations from Both Events!
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      iiSra
                                                                                                                                                                                              Please contact me: I’m interested in marketing opportunities at this event




                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Johnson & Johnson
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Safety Reporting
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sunshine Act
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Us Vs. Ex-Us Training
                                        register@exlpharma.com




                                                                                                                                                                                                                                                                           I wish to receive email updates on ExL Pharma’s upcoming events



                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     merck
                                                                 www.exlpharma.com




                                                                                                                                                                                                                                                                                                                                                                                                                                          Zip
                                                                                              Yes! Register me for the Conference & Workshop:




                                                                                                                                                                                                                                                                                                                                                                                                                                                                               millennium
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Aggregate Spend Contracting
                         888-221-6750




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      pfizer
                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Vertex pharmaceuticals         FMV




                                                                                                                                                                                                                                                                                                                                                                                                                                          State
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Emerging Markets



                                                                                                                                                                                                                                                                                                                                                                            Title




                                                                                                                                                                                                                                                                                                                                                                                                                                                          Fax
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Pub Planning
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance Transparency
                                                                                                                                                            Register me for Conference Only
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Mergers & Acquisitions
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 IP    Grants Systems Process
                                              New York, NY 10018
TO R E G I S T E R


                                              555 8th Avenue,
                                              ExL Events, Inc.
                     866-207-6528




                                              Suite 310
                                                                                                                                                                                                                                                                                                                                                                                                                                                                       SPONSORS &                                                 ASSOcIATION
                                                                                                                                                                                                                                                                                                                                                                                                                                                                       EXHIBITORS:                                                PARTNERS:




                                                                                                                                                                                                                                                                                                                                                                                                                                                          Telephone
                                                                                                                                                                                                                                                                                                                                                                                                              Company




                                                                                                                                                                                                                                                                                                                                                                                                                                Address
                                                                                                                                                                                                                                                                                                                                                                            Name




                                                                                                                                                                                                                                                                                                                                                                                                                                                  Email
                                                                                                                                                                                                                                                                                                                                                                                                                        Dept.




                                                                                                                                                                                                                                                                                                                                                                                                                                          City
                                                                                                                                                                                                                                                                                                                                                                                                                                                                      To Register Call 866-207-6528 or Visit Us at www.exlpharma.com/events/12th-investigator-initiated-trials

Contenu connexe

En vedette

Etikalab servizi
Etikalab serviziEtikalab servizi
Etikalab serviziEtikalab
 
September 1 speech and writing
September 1 speech and writingSeptember 1 speech and writing
September 1 speech and writingJessica Visseau
 
Highlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesHighlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesExL Pharma
 
Writing For The Media 12.11.10
Writing For The Media 12.11.10Writing For The Media 12.11.10
Writing For The Media 12.11.10WCG London
 
Trương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VN
Trương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VNTrương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VN
Trương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VNNghĩa Trương Trung
 
The Tax Deferral Strategy You Haven\'t Heard About
The Tax Deferral Strategy You Haven\'t Heard AboutThe Tax Deferral Strategy You Haven\'t Heard About
The Tax Deferral Strategy You Haven\'t Heard AboutRona Birenbaum BAS CFP CHFS
 
Ftp使用方式 new
Ftp使用方式 newFtp使用方式 new
Ftp使用方式 newga ji
 
3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case Studies
3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case Studies3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case Studies
3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case StudiesSL Corporation
 
SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013Raona
 
SharePoint Day 2012_Visual Workflows
SharePoint Day 2012_Visual Workflows SharePoint Day 2012_Visual Workflows
SharePoint Day 2012_Visual Workflows Raona
 

En vedette (15)

Etikalab servizi
Etikalab serviziEtikalab servizi
Etikalab servizi
 
990413社會住宅與角色1 阿姆斯特丹為例
990413社會住宅與角色1 阿姆斯特丹為例990413社會住宅與角色1 阿姆斯特丹為例
990413社會住宅與角色1 阿姆斯特丹為例
 
September 1 speech and writing
September 1 speech and writingSeptember 1 speech and writing
September 1 speech and writing
 
Highlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring CommitteesHighlights from ExL Pharma's 5th Data Monitoring Committees
Highlights from ExL Pharma's 5th Data Monitoring Committees
 
Writing For The Media 12.11.10
Writing For The Media 12.11.10Writing For The Media 12.11.10
Writing For The Media 12.11.10
 
Trương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VN
Trương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VNTrương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VN
Trương Trung Nghĩa - Đánh giá tình trạng nhập siêu của nền KT VN
 
Footscray park
Footscray parkFootscray park
Footscray park
 
The Tax Deferral Strategy You Haven\'t Heard About
The Tax Deferral Strategy You Haven\'t Heard AboutThe Tax Deferral Strategy You Haven\'t Heard About
The Tax Deferral Strategy You Haven\'t Heard About
 
Personal History
Personal HistoryPersonal History
Personal History
 
Ftp使用方式 new
Ftp使用方式 newFtp使用方式 new
Ftp使用方式 new
 
Merion Menus
Merion MenusMerion Menus
Merion Menus
 
3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case Studies
3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case Studies3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case Studies
3 Industries; 3 Challenges; 3 TIBCO Middleware Monitoring Case Studies
 
SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013SharePoint Apps - SharePoint Day 2013
SharePoint Apps - SharePoint Day 2013
 
SharePoint Day 2012_Visual Workflows
SharePoint Day 2012_Visual Workflows SharePoint Day 2012_Visual Workflows
SharePoint Day 2012_Visual Workflows
 
生活品質與Arduin去機構化過程與應用
生活品質與Arduin去機構化過程與應用生活品質與Arduin去機構化過程與應用
生活品質與Arduin去機構化過程與應用
 

Similaire à ExL Pharma's 12th Investigator Initiated Trials Conference Brochure

Assocham conf grc sept 13
Assocham conf  grc  sept 13Assocham conf  grc  sept 13
Assocham conf grc sept 13subramanian K
 
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, PhiladelphiaExL Pharma
 
2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilities2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilitieschkwagner
 
Demystifying Entrepreneurship for Mature Organizations (Germany)
Demystifying Entrepreneurship for Mature Organizations (Germany)Demystifying Entrepreneurship for Mature Organizations (Germany)
Demystifying Entrepreneurship for Mature Organizations (Germany)Ikhlaq Sidhu
 
Outsourcing risk mitigation and critical success factors
Outsourcing risk mitigation and critical success factorsOutsourcing risk mitigation and critical success factors
Outsourcing risk mitigation and critical success factorsSPAN Infotech (India) Pvt Ltd
 
2010 CRC Showcase - Safety & Security - Safety Culture Management R2.101
2010 CRC Showcase - Safety & Security - Safety Culture Management R2.1012010 CRC Showcase - Safety & Security - Safety Culture Management R2.101
2010 CRC Showcase - Safety & Security - Safety Culture Management R2.101CRC for Rail Innovation
 
Does your company have the big 3 - Life Science Fast Track
Does your company have the big 3 - Life Science Fast TrackDoes your company have the big 3 - Life Science Fast Track
Does your company have the big 3 - Life Science Fast TrackThe Capital Network
 
Innovation and Breakthrough Forum-Leap to Success.
Innovation and Breakthrough Forum-Leap to Success.Innovation and Breakthrough Forum-Leap to Success.
Innovation and Breakthrough Forum-Leap to Success.KMIRC PolyU
 
Entrepreneurship 101: Commercializing University / Hospital Technologies
Entrepreneurship 101: Commercializing University / Hospital TechnologiesEntrepreneurship 101: Commercializing University / Hospital Technologies
Entrepreneurship 101: Commercializing University / Hospital TechnologiesMaRS Discovery District
 
Fast IT Mariano O'Kon, Cisco Live Cancun 2014
Fast IT Mariano O'Kon, Cisco Live Cancun 2014Fast IT Mariano O'Kon, Cisco Live Cancun 2014
Fast IT Mariano O'Kon, Cisco Live Cancun 2014Felipe Lamus
 
pc15222_brochure
pc15222_brochurepc15222_brochure
pc15222_brochureAmy Ripston
 
FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...
FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...
FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...Epstein Becker Green
 
Managing 'Big Data': Federal use cases for real-time data infrastructure
Managing 'Big Data':  Federal use cases for real-time data infrastructureManaging 'Big Data':  Federal use cases for real-time data infrastructure
Managing 'Big Data': Federal use cases for real-time data infrastructureSchneider Electric
 
Conference Using Outsourcing To Strengthen Your Business
Conference Using Outsourcing To Strengthen Your BusinessConference Using Outsourcing To Strengthen Your Business
Conference Using Outsourcing To Strengthen Your BusinessUlad
 
SNW Spring 10 Presentation
SNW Spring 10 PresentationSNW Spring 10 Presentation
SNW Spring 10 PresentationJeff Kubacki
 
How to Boost your Cyber Risk Management Program and Capabilities?
How to Boost your Cyber Risk Management Program and Capabilities?How to Boost your Cyber Risk Management Program and Capabilities?
How to Boost your Cyber Risk Management Program and Capabilities?PECB
 
Jeremy Gilbert - Public Bio
Jeremy Gilbert - Public BioJeremy Gilbert - Public Bio
Jeremy Gilbert - Public Biojgilbert20
 

Similaire à ExL Pharma's 12th Investigator Initiated Trials Conference Brochure (20)

Assocham conf grc sept 13
Assocham conf  grc  sept 13Assocham conf  grc  sept 13
Assocham conf grc sept 13
 
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia6th Clinical Data Disclosure Summit, March 2011, Philadelphia
6th Clinical Data Disclosure Summit, March 2011, Philadelphia
 
2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilities2010 Empiri Stat Corporate Capabilities
2010 Empiri Stat Corporate Capabilities
 
Demystifying Entrepreneurship for Mature Organizations (Germany)
Demystifying Entrepreneurship for Mature Organizations (Germany)Demystifying Entrepreneurship for Mature Organizations (Germany)
Demystifying Entrepreneurship for Mature Organizations (Germany)
 
Outsourcing risk mitigation and critical success factors
Outsourcing risk mitigation and critical success factorsOutsourcing risk mitigation and critical success factors
Outsourcing risk mitigation and critical success factors
 
2010 CRC Showcase - Safety & Security - Safety Culture Management R2.101
2010 CRC Showcase - Safety & Security - Safety Culture Management R2.1012010 CRC Showcase - Safety & Security - Safety Culture Management R2.101
2010 CRC Showcase - Safety & Security - Safety Culture Management R2.101
 
ARP
ARPARP
ARP
 
Does your company have the big 3 - Life Science Fast Track
Does your company have the big 3 - Life Science Fast TrackDoes your company have the big 3 - Life Science Fast Track
Does your company have the big 3 - Life Science Fast Track
 
Innovation and Breakthrough Forum-Leap to Success.
Innovation and Breakthrough Forum-Leap to Success.Innovation and Breakthrough Forum-Leap to Success.
Innovation and Breakthrough Forum-Leap to Success.
 
Entrepreneurship 101: Commercializing University / Hospital Technologies
Entrepreneurship 101: Commercializing University / Hospital TechnologiesEntrepreneurship 101: Commercializing University / Hospital Technologies
Entrepreneurship 101: Commercializing University / Hospital Technologies
 
Fast IT Mariano O'Kon, Cisco Live Cancun 2014
Fast IT Mariano O'Kon, Cisco Live Cancun 2014Fast IT Mariano O'Kon, Cisco Live Cancun 2014
Fast IT Mariano O'Kon, Cisco Live Cancun 2014
 
pc15222_brochure
pc15222_brochurepc15222_brochure
pc15222_brochure
 
FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...
FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...
FDA Cybersecurity Recommendations to Comply with NIST - Wearables Crash Cours...
 
Managing 'Big Data': Federal use cases for real-time data infrastructure
Managing 'Big Data':  Federal use cases for real-time data infrastructureManaging 'Big Data':  Federal use cases for real-time data infrastructure
Managing 'Big Data': Federal use cases for real-time data infrastructure
 
Conference Using Outsourcing To Strengthen Your Business
Conference Using Outsourcing To Strengthen Your BusinessConference Using Outsourcing To Strengthen Your Business
Conference Using Outsourcing To Strengthen Your Business
 
SNW Spring 10 Presentation
SNW Spring 10 PresentationSNW Spring 10 Presentation
SNW Spring 10 Presentation
 
SNW Fall 2009
SNW Fall 2009SNW Fall 2009
SNW Fall 2009
 
How to Boost your Cyber Risk Management Program and Capabilities?
How to Boost your Cyber Risk Management Program and Capabilities?How to Boost your Cyber Risk Management Program and Capabilities?
How to Boost your Cyber Risk Management Program and Capabilities?
 
654L17_E
654L17_E654L17_E
654L17_E
 
Jeremy Gilbert - Public Bio
Jeremy Gilbert - Public BioJeremy Gilbert - Public Bio
Jeremy Gilbert - Public Bio
 

Plus de ExL Pharma

9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best PracticesExL Pharma
 
CMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, BostonCMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, BostonExL Pharma
 
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJExL Pharma
 
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VAExL Pharma
 
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyThe 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyExL Pharma
 
6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York CityExL Pharma
 
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...ExL Pharma
 
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, MiamiExL Pharma
 
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...ExL Pharma
 
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, PhiladelphiaExL Pharma
 
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...ExL Pharma
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsExL Pharma
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceExL Pharma
 
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenHighlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenExL Pharma
 
Highlights from ExL Pharma's 2nd Digital Pharma Europe
Highlights from  ExL Pharma's 2nd Digital Pharma EuropeHighlights from  ExL Pharma's 2nd Digital Pharma Europe
Highlights from ExL Pharma's 2nd Digital Pharma EuropeExL Pharma
 
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceHighlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceExL Pharma
 
Highlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationHighlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationExL Pharma
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical TrialsExL Pharma
 
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's  2nd Pharmaceutical Managed MarketsHighlights from ExL Pharma's  2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's 2nd Pharmaceutical Managed MarketsExL Pharma
 

Plus de ExL Pharma (20)

9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices9th Medical Science Liaison Best Practices
9th Medical Science Liaison Best Practices
 
CMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, BostonCMO Quality Oversight & Risk Management, April 2011, Boston
CMO Quality Oversight & Risk Management, April 2011, Boston
 
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
13th Investigator Initiated Trials, April 2011, Basking Ridge, NJ
 
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
2nd Annual Proactive GCP Compliance, April 2011, Arlington, VA
 
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, GermanyThe 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
The 3rd Annual Digital Pharma Europe, March 2011, Ingelheim, Germany
 
6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City6th Annual Support for Independent Medical Education, March 2011, New York City
6th Annual Support for Independent Medical Education, March 2011, New York City
 
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
5th Forecasting and Optimizing the Clinical Supply Chain, March 2011, Philade...
 
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
4th Lean Sigma & Kaizen for Pharma R&D Conference, March 2011, Miami
 
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
2nd Annual Clinical Site Feasibility, Selection, and Startup, March 2011, Phi...
 
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia6th Latin America Clinical Trials Conference, March 2011, Philadelphia
6th Latin America Clinical Trials Conference, March 2011, Philadelphia
 
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
2nd Patient Engagement Summit: New Technologies for Engaging Patients in Clin...
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated Trials
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best Practices
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP Compliance
 
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & KaizenHighlights from ExL Pharma's 3rd Lean Sigma & Kaizen
Highlights from ExL Pharma's 3rd Lean Sigma & Kaizen
 
Highlights from ExL Pharma's 2nd Digital Pharma Europe
Highlights from  ExL Pharma's 2nd Digital Pharma EuropeHighlights from  ExL Pharma's 2nd Digital Pharma Europe
Highlights from ExL Pharma's 2nd Digital Pharma Europe
 
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research ComplianceHighlights from ExL Pharma's 4th Clinical Billing & Research Compliance
Highlights from ExL Pharma's 4th Clinical Billing & Research Compliance
 
Highlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & CommunicationHighlights from ExL Pharma's Site Selection, Activation & Communication
Highlights from ExL Pharma's Site Selection, Activation & Communication
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
 
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's  2nd Pharmaceutical Managed MarketsHighlights from ExL Pharma's  2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
 

Dernier

2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxDr. Asif Anas
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...CaraSkikne1
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17Celine George
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationMJDuyan
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?TechSoup
 

Dernier (20)

2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptx
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive Education
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?
 

ExL Pharma's 12th Investigator Initiated Trials Conference Brochure

  • 1. Prices Increase After August 13th PROUDLY PRESENTS original The InvestIgator 12th is still the best! Join us and share Best Practices with InItIated trIals organizations New IIT Content includes Aggregate Spend, M&A, including: Emerging Markets, Publication Planning and more! abbott September 27-28, 2010 allergan Hyatt regency San FranciSco airport - burlingame, ca { astraZeneca 7th MSL Best Practices celgene Co-LoCated Register Today and Gain Access to Presentations from Both Events! centocor Safety Reporting Sunshine Act iiSra Johnson & Johnson Us Vs. Ex-Us Training merck FMV Aggregate Spend Contracting millennium Emerging Markets Pub Planning Compliance Transparency pfizer Vertex pharmaceuticals Mergers & Acquisitions IP Grants Systems Process SPONSORS & ASSOcIATION EXHIBITORS: PARTNERS: To Register Call 866-207-6528 or Visit Us at www.exlpharma.com/events/12th-investigator-initiated-trials
  • 2. WHO WILL BE IN SponSorSHip ATTENDANCE? and exHibiting • Investigator Initiated/Sponsored Trials opportunitieS • Investigator Research do you want to spread the word about your or- • Medical Affairs/Field Medical Affairs ganization’s solutions and services to potential • MSL Managers/Field MSLs clients who will be attending this event? take ad- • Clinical Research Associates vantage of the opportunity to exhibit, present an • Phase IV educational session, host a networking event, or distribute promotional items to attendees. exl • Legal & Regulatory Affairs will work closely with you to customize a package • Clinical and Research Investigators that will suit all of your needs. to learn more about • Site Management these opportunities, contact lucas carrasco, busi- • Post-Market Studies ness development, by calling 212-400-6231 or by • Clinical Affairs emailing lcarrasco@exlpharma.com. • Clinical Data Analysts rave reviews from exl’s 11th investigator-initiated trials: “this was an excellent meeting. it covered a broad range “great presenter and covered exactly what i was looking of important issues. Speakers are very knowledgeable and for!” Rina Patel, Medical affairs Manager, aLLerGan very approachable,” “clear, concise info w/good value-added Randy Leeder, Clinical Project Manager, Leo PharMa recommendations,” “excellent, as usual,” Lindsay Tollen, Senior Manager, CePhaLon Therica Miller, Manager Clinical trials office, nevada Cancer institute “great topics - important issues,” “yes! great presentations and workshops! good Muriel Siadak, associate Medical Director, SeattLe GenetiCS discussions,” Teresa Pena, aD Scientific exchange, uCB “great! exceeded expectations. new data/material; well “thoughtful, interactive constantly touching back to done presentations, excellent value drive conference!” mission, goals, value argument,” Patrician Westergren, Product Mgr, iiSr, MeDnet SoLutionS Laura Williams, Principal Grant and Contract administrator, uMn “yes – no improvements needed,” Coleen Myers, Clinical research Manager, CePhaLon HOTEL INFORMATION Hyatt Regency reward yourself with a stay at the Four diamond Hyatt regency San San FRanciSco Francisco airport hotel. experience our ideal location on San Francisco airport bay – just 15 minutes from the excitement of downtown San Francisco 1333 Bayshore Highway, or the technology corridor of Silicon Valley and only seven minutes from San Francisco international airport, you’ll enjoy easy access to all the Burlingame, California, sanfrancisco airport attractions surrounding our luxury hotel. USA 94010 Tel: +1 650 347 1234    Fax: +1 650 696 2669 reSerVationS: please make reservations before September 5th to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
  • 3. day one, monday, September 27, 2010 8:00 registration and Continental Breakfast for WorkshoP PartiCiPants WorkshoP Pre-ConferenCe PRE-cONfERENcE WORkSHOP 9:00 examining the compliance, execution and data management challenges of tracking aggregate Spend Legal Overview of Sunshine Act • Compliance Focus • Managing Master Spend Data · Implementing efficient tracking systems · Identifying data sources and data flow associated with IITs · Key compliance challenges · Management processes for data · Identifying and mitigating risks · Analyzing and reporting systems · Addressing HCP interactions concerning payments · Implementing process improvements Wendy Tsuei, Sr. Program Manager, Corporate Compliance, AllergAn · Ensuring data integrity Ahmad Chaudhri, Director, Business Analytics, AllergAn Allocated Time for Questions, Answers and Scenarios for maximum participant involvement 10:30 netWorking and refreshment Break 12:00 lunCh for WorkshoP attendees main ConferenCe oPens 12:00 registration oPens for main ConferenCe 3:45 understanding the role of publication planning Valérie Philippon, PhD, Director, Publications, VerTeX PHArMACeUTICAlS 1:00 chairperson’s welcome • Publication Planning Overview Karen Bartels, RN, OCN, MBA, PMP, Clinical Project Manager, • Incorporating the Publication Clause in the IIT Agreement ASTrAZeneCA & eXeCUTIVe DIreCTOr, IISrA • Maximizing the Value of Publications • Differences between IIT and Clinical Publication Review HOW M&A AffEcTS IIT PROgRAMS ANd TRIAlS IISRA uPdATE & ROuNdTABlES 1:15 adopting and implementing processes while maintaining the integrity of trials obtained through 4:30 investigator initiated Sponsored research mergers and acquisitions association update Karen Bartels, RN, OCN, MBA, PMP, Clinical Project Manager, Alex Kostek, Global Investigator Initiated Research Group Leader, PFIZer ASTrAZeneCA & eXeCUTIVe DIreCTOr, IISrA Deborah Cassel, Associate Director, Global Center for Scientific Affairs, IISRA values your input. Your feedback has significantly Merck Investigator Studies Program (MISP), MerCK contributed to the development of Standards and Best • Process overview of compliantly and efficiently taking on new Practice Guideline and position statements. IITs as a result of mergers and acquisitions • Determining which IITs should be adopted and which can • Membership and organizational milestones contractually be let go • Standards and Best Practice Committee Deliverables • Guidance on planning and executing integration plans in • Membership committee and related subcommittees different scenarios ONlINE IIT APPROvAl SuBMISSION PROcESS ROuNdTABlES dIScuSSION 2:15 case report - on-line automation of iit grants 5:00 cocktail reception management: System design to global implementation roundtable discussion. Sessions on topics including: Anton ehrhardt, PhD, Sr. Medical Director, • Aggregate Spend MIllenIUM: THe TAKeDA OnCOlOgY COMPAnY • IISRA Breakout • Advantages and challenges of building a completely custom • Global IITs system • Publication Planning • Integration with existing infrastructure to support Aggregate • Safety Reporting Spend Reporting & Transparency Initiatives • Grant Management Systems • Why you should consider doing this too Attendees will have additional topic roundtables to choose from focusing on MSL-related topics 3:15 netWorking and refreshment Break 6:00 Close of day one to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
  • 4. day two, tueSday, September 28, 2010 main ConferenCe 8:00 Continental Breakfast for ConferenCe of program has its benefits, but also its challenges.  I will discuss PartiCiPants these and highlight some key points that, based on my experience, should be taken into account when setting up a competitive 8:50 chairperson’s day one recap program.  These include: Karen Bartels, RN, OCN, MBA, PMP, Clinical Project Manager, • Healthcare Professional payments ASTrAZeneCA & eXeCUTIVe DIreCTOr, IISrA • Program set up • Internal review committee’s role • Review process and meeting kEy PERfORMANcE INdIcATORS • Post meeting activities 9:00 How to terminate an iit and maintain relationships PuBlIcATION Of IITS with investigators Ashwaq Hermes, PharmD Sr. Clinical Science ManagerGlobal 11:45 How the Sunshine act has impacted iit programs and Pharmaceutical Research & Development, ABBOTT After several months of hard work generating adequate interest, investigator interactions completing the proposal, the protocol, consent form, IRB approval, Dennis Decktor, PhD, MBA, Senior Director, Medical Affairs, CRFs and contracts, the project officially starts! Months later, it is CenTOCOr OrTHO-BIOTeCH not progressing! What are the options? • What are the causes of the lack of progress? Are they fixable? • What if they are not? How do you terminate the project? 12:30 lunCh • How do you terminate the project while preserving your relationship with the investigator(s)? INTERNATIONAl IITS 1:30 iit contracting Strategies kEyS TO SuccESSful IIT PROgRAMS Annette S. Meints, RN, MS, PMP, Clinical Research Manager II, 9:45 walking the compliance tightrope – do you Have a GPRD, ABBOTT This session will provide an overview, strategies and relevant case Funambulist on your Staff? examples to draw from.  The following items will be included in Joseph Bray, Product Lead, UBC: envision the discussion:   Compliance today is a hot button discussion on everyone’s ·  Contract structure, format and key components agenda. What is an acceptable risk for one company is toxic to ·  Intellectual Property – Whose data is it? another. What are the rules? Who gets to interpret them? Is your ·  Publication rights SOP compliant in today’s world? How do we bring global ·  Confidentiality concerns IIT programs together under one set of working practices? ·  Indemnification What constitutes influence? Small or large: biotech, Pharma, ·  Maximizing compliance and mitigating delays or device company, we all have a lot of the same questions.   In this session we will attempt to look at both sides of the many decisions each company must make when developing a INTERNATIONAl IITS compliant IIT program. • Initial submission – Who’s idea is it? • Review committee invitations – Does my opinion count? 2:15 effective Strategies for managing investigator initiated • Multisite or coop studies – My contract is with who? trials in emerging markets • Payments – How do you measure study progress? Kevin Douglass, Associate Director/Investigator Initiated Research (IIR) • Are we there yet? – What is your definition of done? Manager, Emerging Markets, PFIZer • Who cares how they do it over there? – You do, it’s a global • How does the process differ from US IITs? program • Managing multiple emerging market sites • Dealing with differences in culture while not compromising the integrity of the IIT 10:30 netWorking and refreshment Break cOMPETITIvE gRANT PROgRAM 3:00 ChairPerson’s Closing remarks; ConferenCe adjourns 11:00 implementing competitive grants programs in place of iir Submissions Alison Curtin, Associate Director, Global IIR Primary Care, PFIZer A product team or disease area may choose to implement a competitive grant program in addition to or in place of accepting individual IIR submissions. This type of program typically has a defined set of research criteria,   which is broadly publicized to an appropriate investigator group through one of several possible routes (ie professional journal or website).  Submitted applications are then are reviewed and approved by an external advisory committee, in lieu of a formal internal review.  This type to regiSter call 866-207-6528 or ViSit www.exlpHarma.com
  • 5. media Partners Group Discount proGram Five Ways to reGister: Save 25% per person when Registering Four* Fax: 888-221-6750 For every three simultaneous registrations from your company, you Mail: exl events, Inc. will receive a fourth complimentary registration to the program (must register 4 at one time) this is a savings of 25% per person. 555 8th Ave, Ste 310 new York, nY 10018 registration information Save 15% per person when Registering Three* Phone: 866-207-6528 Can only send three? You can still save 15% off of every registration. Online: www.exlpharma.com email: registration@exlpharma.com To find out more on how you can take advantage of these group discounts, please call 212-400-6240 866-207-6528. *All discounts are taken off of the standard pricing, discount offers may not be combined reGistration Fees For attenDinG exL’s 12th InvestIgator InItIated Make checks payable to ExL Events, Inc. and write code P1605 trIals: on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference. eaRLy BiRD PRicing Cancellations: If you need to cancel your registration for an upcom- Register by Friday August 13th to Take Advantage ing ExL conference, please note the following policies derived from of Early Bird Pricing: the Start Date of the event: • Four weeks or more: A full refund (minus a $95 processing fee), or Conference + Workshop $1995 a voucher to another ExL event valid for two years from the voucher Conference Only $1695 issue date. • Four weeks or Less: A voucher to another ExL event valid for two years from the voucher issue date. StanDaRD PRicing • To receive a refund or voucher, please fax your request to 888-221- Register After August 13th: 6750. Conference + Workshop $2195 • There will be an administrative charge of $300 to substitute, Conference Only $1895 exchange and/or replace attendance badges with a colleague oc- curring within five business days of the conference. Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a onSite PRicing suitable replacement will be made. Conference + Workshop $2295 *The opinions of this faculty do not necessarily reflect those of the Conference Only $1995 companies they represent or ExL Events, Inc.* Questions? comments? Do you have a question or comments that you would like to be addressed at this event? Would you like to get involved as a speaker or discussion leader? Please email Conference Director, Ethan Denkensohn at edenkensohn@exlpharma.com
  • 6. Prices Increase After August 13th PROUDLY PRESENTS Exp. Date: PLEASE MENTION PRIORITY CODE: P121 original The 12th InvestIgator 555 8th Avenue, Suite 310 InItIated trIals is still the best! New York, NY 10018 Join us and share Best Practices with organizations including: New IIT Content includes Aggregate Spend, M&A, Emerging Markets, Publication Planning and more! abbott September 27-28, 2010 allergan Hyatt regency San FranciSco airport - burlingame, ca Name on Card Card Number astraZeneca { Signature celgene 7th MSL Best Practices Co-LoCated Register Today and Gain Access to centocor Presentations from Both Events! iiSra Please contact me: I’m interested in marketing opportunities at this event Johnson & Johnson Safety Reporting Sunshine Act Us Vs. Ex-Us Training register@exlpharma.com I wish to receive email updates on ExL Pharma’s upcoming events merck www.exlpharma.com Zip Yes! Register me for the Conference & Workshop: millennium Aggregate Spend Contracting 888-221-6750 pfizer Vertex pharmaceuticals FMV State Emerging Markets Title Fax Pub Planning Compliance Transparency Register me for Conference Only Mergers & Acquisitions IP Grants Systems Process New York, NY 10018 TO R E G I S T E R 555 8th Avenue, ExL Events, Inc. 866-207-6528 Suite 310 SPONSORS & ASSOcIATION EXHIBITORS: PARTNERS: Telephone Company Address Name Email Dept. City To Register Call 866-207-6528 or Visit Us at www.exlpharma.com/events/12th-investigator-initiated-trials